Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-21

Clinical Trial Update: Efficacy of Intravenous Levetiracetam in Neonatal Seizures [Phase 1, Phase 2]

View source ↗

Summary

A combined Phase 1/2 clinical trial investigated intravenous levetiracetam for neonatal seizures; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Richard H. Haas | Conditions: Neonatal Seizures | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-08-21